Drug intelligence / Profile preview

Jinshui Huanxian

Development stage
Preclinical
Lead developer
Henan University of Chinese Medicine
Administration
Oral
01

Overview

Jinshui Huanxian is a proprietary Chinese herbal compound prescription formulated to treat pulmonary fibrosis and related respiratory conditions. It is composed of 11 medicinal herbs including Ginseng Radix et Rhizoma (ginseng), Ophiopogonis Radix (ophiopogon), Rehmanniae Radix (rehmannia), Trichosanthis Fructus (trichosanthes fruit), Fritillariae Thunbergii Bulbus (fritillaria bulb), Moutan Cortex (moutan bark), Epimedii Herba (epimedium/herba epimedii), Ginkgo Semen (ginkgo seed), Pulsatillae Radix (pulsatilla root), Coicis Semen (coix seed/Job’s tears) and Citri Reticulatae Pericarpium (tangerine peel)[1]. The formula has demonstrated efficacy in animal models for reducing lung tissue damage and collagen deposition caused by bleomycin-induced pulmonary fibrosis. Mechanistically, it exerts anti-fibrotic effects by inhibiting oxidative stress—specifically downregulating NADPH oxidase 4 and upregulating Nuclear Factor Erythroid 2-Related Factor 2 in lung tissues—and modulates multiple molecular pathways involved in inflammation and fibrogenesis[1][4]. Clinical use is based on traditional Chinese medicine principles targeting "lung-kidney qi deficiency" and "phlegm-blood stasis"[2][4]. Pharmacokinetic studies have identified several major bioactive components such as ginsenosides Rb1/Rc/Rb2, icariin, catalpol, apigenin-7-glucoside among others[3][5].

Brand names
Jinshui Huanxian
Other names
Jinshui Huanxian formulaJHFJinshui-Huanxian granulesJHGs
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NOX4 (NADPH oxidase 4)

Beyond the preview

Go deeper on Jinshui Huanxian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinshui Huanxian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call